Overview

A class action lawsuit has been filed against Dentsply Sirona, Inc. (“Dentsply” or the “Company”) (NASDAQ: XRAY) and certain of the Company’s former and current senior executive officers alleging violations of the federal securities laws.  The Dentsply class action lawsuit is brought on behalf of all persons and entities who purchased or otherwise acquired Dentsply common stock between December 1, 2022, and November 6, 2024, both dates inclusive (the “Class Period”).  Investors have until January 27, 2025, to seek appointment as lead plaintiff in the Dentsply class action lawsuit.

Dentsply manufactures professional dental products, for example, computer-aided design and manufacturing systems (“CAD/CAM”), imaging equipment, motorized dental handpieces, consumables (e.g., files, sealers, needles), implants, prosthetics, and orthodontics, such as clear aligners.  Dental and medical devices sold by Dentsply in the United States, including clear aligners, are generally classified by the U.S. Food and Drug Administration (“FDA”) into a category that makes them subject to the same regulations that apply to all medical devices.  Dentsply’s four segments are: Connected Technology Solutions, Essential Dental Solutions, Wellspect Healthcare, and Orthodontic and Implant Solutions, which includes SureSmile, an aligner solution provided through clinician offices, and Byte, a direct-to-consumer (“DTC”) aligner solution.  In 2023, Orthodontic and Implant Solutions, which includes SureSmile and Byte, accounted for more than 26%of Dentsply’s net sales by segment.

Prior to the start of the Class Period, on December 31, 2020, Dentsply paid $1.04 billion in cash to acquire Byte, a manufacturer of affordable, “doctor-directed,” DTC clear dental aligners.  According to Dentsply, Byte held a “leadership position in the rapidly growing direct-to-consumer, doctor-directed clear aligner market.”

The Dentsply class action lawsuit alleges that Defendants, throughout the Class Period, provided materially false and/or misleading statements and failed to disclose material adverse facts about the Company’s business, operations, and prospects to make the statements made, in light of the circumstances under which they were made, not false and misleading.  Specifically, Defendants failed to disclose that: (1) Dentsply targeted low-income people who did not have access to good oral hygiene education, a dentist, or dental insurance, which often meant patients signing up for Byte had underlying dental issues that would have made them ineligible for treatment; (2) the push for Byte growth and sales commissions caused sales employees to sell to contraindicated patients; (3) as a result of the above, the Byte patient onboarding workflow did not provide adequate assurance that contraindicated patients did not enter treatment; (4) before and during the Class Period, reports of Byte patient injuries were pouring in; (5) Dentsply knew that its Byte aligners were causing severe patient injuries for years but did little to investigate those injuries or notify the FDA; (6) Dentsply had no systems in place to notify the FDA of these injuries, which the Company is required to do within 30 days of learning of a problem; (7) the FDA had received a sharp uptick in reports of serious injuries from Byte patients; (8) as a result of the above, Dentsply materially overstated the goodwill value of Byte; and (9) as a result of the above, Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

*          *          *

If you purchased or otherwise acquired Dentsply common stock between December 1, 2022, and November 6, 2024, both dates inclusive, and you wish to serve as lead plaintiff in this lawsuit, we encourage you to submit your information to DiCello Levitt LLP via the form on this page. 

You can also contact DiCello Levitt partner Brian O’Mara by calling (888) 287-9005 or at [email protected]. 

The deadline to apply to the Court to serve as lead plaintiff in the Dentsply class action lawsuit is January 27, 2025.